Betamethasone vs Dextrose Injections for Trigger Finger
Official title: Comparison of Ultrasound-Guided Betamethasone and Dextrose Injections in the Treatment of Trigger Finger: A Randomized Controlled Trial
Run by Istanbul University - Cerrahpasa · NCT07681804 · Data updated 2026-11-12
This trial tests whether an ultrasound-guided betamethasone shot works better than a dextrose injection for people with trigger finger.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | Istanbul University - Cerrahpasa Academic / other |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | June 30, 2026 |
| Main results expected | April 2027 |
| Study ends | May 2027 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07681804 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–75 with clinically diagnosed trigger finger lasting at least four weeks and no recent finger injections or surgery.
✕Probably not a fit
Patients with conditions or therapies that confound outcomes or who have exclusion criteria (e.g., active infection, uncontrolled diabetes or hypertension) may not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial compares two ultrasound-guided injections for trigger finger: betamethasone, a corticosteroid, and a dextrose solution. Participants aged 18 to 75 with symptoms for at least four weeks are assigned to receive one of the injections with lidocaine under sterile conditions. The study measures pain on the Numeric Rating Scale as the primary outcome, with secondary outcomes including triggering severity, hand function, grip and pinch strength, and fine motor skills over a 12-week follow-up. The aim is to determine which injection provides greater symptom relief and functional improvement in this condition.
Why it matters
Potential benefit: If successful, the preferred injection could provide better pain relief and hand function with potentially fewer adverse effects.
How similar studies have gone: Previous corticosteroid injections are commonly effective for trigger finger, while evidence for dextrose is limited; this head-to-head trial addresses a gap in comparative data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 75 years * Clinical diagnosis of trigger finger * Presence of symptoms for at least 4 weeks Exclusion Criteria: * Previous surgery on the affected finger * Injection treatment to the affected finger within the previous 3 months * Active local or systemic infection * Active malignancy * Active inflammatory rheumatic disease (e.g., rheumatoid arthritis, ankylosing spondylitis, polymyalgia rheumatica, vasculitis) * Uncontrolled diabetes mellitus and/or uncontrolled hypertension * Autoimmune connective tissue diseases (e.g., systemic lupus erythematosus, antiphospholipid syndrome, systemic sclerosis, Sjögren syndrome, polymyositis, dermatomyositis, adult-onset Still's disease) * Coagulopathy that increases the risk of injection procedures * Pregnancy * Known allergy or hypersensitivity to lidocaine, betamethasone, or dextrose * Mental impairment or severe psychiatric disorder that may interfere with study participation or informed consent
Where it's running
-
Istanbul University - Cerrahpasa, Cerrahpasa Faculty of Medicine
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Merve Yıldız, MD
- Email: merveyildizdr@gmail.com
- Phone: +905350229993
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-Level Laser Therapy for Trigger Finger
This study tests whether low-level laser therapy can help people with trigger finger see if it reduces pain and improves finger movement.
-
Longitudinal versus transverse A1 pulley incision for trigger finger
This trial will test whether a straight (longitudinal) or a crease-based (transverse) skin incision leads to better hand function, less pain, and improved scarring after open A1 pulley release in adults with trigger finger.
-
Comparing a finger splint, paraffin baths, and peloidotherapy for trigger finger
This tests whether a finger splint, paraffin baths, or peloidotherapy works best to reduce pain and catching in adults 18–75 with a single trigger finger.
-
Ultrasound-guided needle knife release for trigger finger treatment
This study is testing a new needle procedure using ultrasound to see if it can help people with trigger finger who haven't found relief from other treatments.
-
Comparing treatments for Trigger Finger using shock wave therapy and splints
This study is testing whether shock wave therapy alone, shock wave therapy with splints, or just splints works best to relieve pain and improve function for people with Trigger Finger.
-
Treatment for trigger finger using a night orthosis after cortisone injection
This study tests if wearing a special night splint after a cortisone shot can help people with trigger finger feel better and use their hands more easily.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.